5564 related articles for article (PubMed ID: 29628290)
1. The Immune Landscape of Cancer.
Thorsson V; Gibbs DL; Brown SD; Wolf D; Bortone DS; Ou Yang TH; Porta-Pardo E; Gao GF; Plaisier CL; Eddy JA; Ziv E; Culhane AC; Paull EO; Sivakumar IKA; Gentles AJ; Malhotra R; Farshidfar F; Colaprico A; Parker JS; Mose LE; Vo NS; Liu J; Liu Y; Rader J; Dhankani V; Reynolds SM; Bowlby R; Califano A; Cherniack AD; Anastassiou D; Bedognetti D; Mokrab Y; Newman AM; Rao A; Chen K; Krasnitz A; Hu H; Malta TM; Noushmehr H; Pedamallu CS; Bullman S; Ojesina AI; Lamb A; Zhou W; Shen H; Choueiri TK; Weinstein JN; Guinney J; Saltz J; Holt RA; Rabkin CS; ; Lazar AJ; Serody JS; Demicco EG; Disis ML; Vincent BG; Shmulevich I
Immunity; 2018 Apr; 48(4):812-830.e14. PubMed ID: 29628290
[TBL] [Abstract][Full Text] [Related]
2. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
[TBL] [Abstract][Full Text] [Related]
3. Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen.
Ghadimi D; de Vrese M; Heller KJ; Schrezenmeir J
Int Immunopharmacol; 2010 Jun; 10(6):694-706. PubMed ID: 20381647
[TBL] [Abstract][Full Text] [Related]
4. Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures.
Wang T; Li T; Li B; Zhao J; Li Z; Sun M; Li Y; Zhao Y; Zhao S; He W; Guo X; Ge R; Wang L; Ding D; Liu S; Min S; Zhang X
Front Immunol; 2022; 13():805184. PubMed ID: 35154121
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
6. PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients.
Wu D; Liu Y; Pang N; Sun M; Wang X; Haridia Y; Zhao F; Qin Y; Fan W; Guo X; Ding J
Medicine (Baltimore); 2019 Oct; 98(43):e17608. PubMed ID: 31651870
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Pan-Cancer Analysis of MEIS1 in Human Tumors as Prognostic Biomarker and Immunotherapy Target.
Li H; Tang Y; Hua L; Wang Z; Du G; Wang S; Lu S; Li W
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836180
[TBL] [Abstract][Full Text] [Related]
8. Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories.
Mizuno S; Yamaguchi R; Hasegawa T; Hayashi S; Fujita M; Zhang F; Koh Y; Lee SY; Yoon SS; Shimizu E; Komura M; Fujimoto A; Nagai M; Kato M; Liang H; Miyano S; Zhang Z; Nakagawa H; Imoto S
Sci Rep; 2021 Aug; 11(1):15713. PubMed ID: 34344966
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
Front Immunol; 2021; 12():734646. PubMed ID: 34795663
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers.
Ekiz HA; Huffaker TB; Grossmann AH; Stephens WZ; Williams MA; Round JL; O'Connell RM
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30721153
[TBL] [Abstract][Full Text] [Related]
11. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.
Xie F; Zhang J; Wang J; Reuben A; Xu W; Yi X; Varn FS; Ye Y; Cheng J; Yu M; Wang Y; Liu Y; Xie M; Du P; Ma K; Ma X; Zhou P; Yang S; Chen Y; Wang G; Xia X; Liao Z; Heymach JV; Wistuba II; Futreal PA; Ye K; Cheng C; Xia T
Clin Cancer Res; 2020 Jun; 26(12):2908-2920. PubMed ID: 31911545
[TBL] [Abstract][Full Text] [Related]
12. The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP.
Takahashi N; Saitoh T; Gotoh N; Nitta Y; Alkebsi L; Kasamatsu T; Minato Y; Yokohama A; Tsukamoto N; Handa H; Murakami H
BMC Immunol; 2017 May; 18(1):26. PubMed ID: 28511637
[TBL] [Abstract][Full Text] [Related]
13. Integrated Genomic Characterization of the Human Immunome in Cancer.
Li Y; Burgman B; McGrail DJ; Sun M; Qi D; Shukla SA; Wu E; Capasso A; Lin SY; Wu CJ; Eckhardt SG; Mills GB; Li B; Sahni N; Yi SS
Cancer Res; 2020 Nov; 80(21):4854-4867. PubMed ID: 32855206
[TBL] [Abstract][Full Text] [Related]
14. Role of Th1/Th2 cytokines in serum on the pathogenesis of chronic hepatitis C and the outcome of interferon therapy.
Zhang L; Hao CQ; Miao L; Dou XG
Genet Mol Res; 2014 Nov; 13(4):9747-55. PubMed ID: 25501184
[TBL] [Abstract][Full Text] [Related]
15. Cancer type-dependent correlations between TP53 mutations and antitumor immunity.
Li L; Li M; Wang X
DNA Repair (Amst); 2020 Apr; 88():102785. PubMed ID: 32007736
[TBL] [Abstract][Full Text] [Related]
16. CRI iAtlas: an interactive portal for immuno-oncology research.
Eddy JA; Thorsson V; Lamb AE; Gibbs DL; Heimann C; Yu JX; Chung V; Chae Y; Dang K; Vincent BG; Shmulevich I; Guinney J
F1000Res; 2020; 9():1028. PubMed ID: 33214875
[TBL] [Abstract][Full Text] [Related]
17. TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth.
Standiford TJ; Kuick R; Bhan U; Chen J; Newstead M; Keshamouni VG
Oncogene; 2011 May; 30(21):2475-84. PubMed ID: 21278795
[TBL] [Abstract][Full Text] [Related]
18. Augmented interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in blood mononuclear cells in myasthenia gravis.
Link J; Navikas V; Yu M; Fredrikson S; Osterman PO; Link H
J Neuroimmunol; 1994 May; 51(2):185-92. PubMed ID: 8182116
[TBL] [Abstract][Full Text] [Related]
19. Immunogenomic characterization in gastric cancer identifies microenvironmental and immunotherapeutically relevant gene signatures.
Han X; Lu H; Tang X; Zhao Y; Liu H
Immun Inflamm Dis; 2022 Jan; 10(1):43-59. PubMed ID: 34582114
[TBL] [Abstract][Full Text] [Related]
20. Immune gene signature delineates a subclass of thyroid cancer with unfavorable clinical outcomes.
Zhi J; Yi J; Tian M; Wang H; Kang N; Zheng X; Gao M
Aging (Albany NY); 2020 Apr; 12(7):5733-5750. PubMed ID: 32240105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
